Eczema Cream Recalled for Having Potentially Life-Threatening Bacteria: FDA Notice

A notice published on the FDA’s website says the cream could be contaminated with a type of staphylococcus bacteria.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

A type of cream used to treat eczema and other conditions is under recall after it was found to be contaminated with a type of staphylococcus bacteria, according to a notice published on the Food and Drug Administration’s (FDA) website on Tuesday.

Drug company Pharmacal issued a recall for its Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, sold under the MG217 brand, for having potentially the life-threatening bacteria, Staphylococcus aureus.